Back
Speaker illustration

Doctor Spyridon Maragkoudakis

General Hospital St. George, Chania (Greece)

Member of:

European Society of Cardiology
Heart Failure Association

Presentations

The potential protective effect of dapagliflozin on the development of cardiotoxicity in cancer patients after one year of observation.

Event: ESC Congress 2024

Topic: Antidiabetic Pharmacotherapy

Session: Real-world evidence on the cardiovascular effects of therapies for diabetes

Access
Like
Thumbnail

The potentially protective effect of dapagliflozin on the development of cardiotoxicity in cancer patients

Event: ESC Congress 2023

Topic: Cardio-Oncology

Session: Cardiotoxicity: mechanisms, biomarkers, and treatment

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources